Schrodinger Inc

-0.13 (-0.49%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.86B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$30.89 Million
Adjusted EPS-$0.64
See more estimates
10-Day MA$25.82
50-Day MA$28.41
200-Day MA$29.07
See more pivots

Schrodinger Inc Stock, NASDAQ:SDGR

1540 Broadway, 24th floor, New York, New York 10036-4041
United States of America
Phone: +
Number of Employees: 664


Schr?¶dinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.